Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations.
Four groups of ten nine-month-old Nelore heifers were used for this study. Each group received one of four foot-and-mouth disease (FMD) trivalent vaccines for the duration of the experiment. The four vaccine formulations (Normal, 2X, 4X and 8X) differed in 140S content to determine the serological reactivities to FMD virus (FMDV) nonstructural proteins 2C, 3ABC and 3D. Vaccination was by the intramuscular administration of vaccine on day 0, 180 and 360. Bleedings were done at 30 days post vaccination (dpv), 90 dpv, 30 days post revaccination (dpr), 90 dpr, and 30 days post third administration (dprr). There was a general tendency to have higher mean 3D responses with increased vaccine application but not with increased concentration of antigen. With 2C and 3ABC this tendency was not seen, neither with repeated application of vaccine nor with increased antigen concentration. All individual animal observations to 2C and 3ABC remained within three standard deviations of the average observed for naive bovids. Percent of positive (PP) reactions was determined using an ELISA for nonstructural proteins 2C, 3ABC and 3D expressed in baculovirus as previously described. A value of > 25 PP to 2C or 3ABC could be considered as an indication of previous infection or of the presence of viral activity. PP results between 18 and 25 PP suggest viral activity and animals should be retested. Those responses below 15 PP are suggestive of vaccination or naive status. As diagnosis in the laboratory is not divorced from the field epidemiological scene, the intermediate zone between 10 and 20 PP should be considered and acted upon according to the overall zoosanitary situation of that country or region and the purposes of the ongoing FMD control efforts.
Lubroth
J
J
United States Department of Agriculture, National Veterinary Services Laboratories, Greenport, NY, USA.
López
A
A
Ramalho
A K
AK
Meyer
R F
RF
Brown
F
F
Darsie
G C
GC
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis* / Q000096:biosynthesis; D000956:Antigens, Viral / Q000276:immunology*; D005537:Aphthovirus / Q000276:immunology*; D016367:Baculoviridae; D002417:Cattle; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005536:Foot-and-Mouth Disease / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D014611:Vaccination / Q000662:veterinary; D014764:Viral Proteins / Q000032:analysis*; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000592:standards
D000914:Antibodies, Viral; D000956:Antigens, Viral; D014764:Viral Proteins; D014765:Viral Vaccines